HCW Biologics Inc.

HCWB · Nasdaq · SIC 2834: Pharmaceutical Preparations
119
SEC Filings

Business Summary

PART I . Overview HCW Biologics Inc. (HCW Biologics or the Company) is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. We have created novel compounds that represent a new class of drugs that we believe have the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. Among other things, we hav...

Next Earnings

Q2 FY2026 — expected 2026-09-13

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionHCWBdiscussed_in_filing Cybersecurity
topic_mentionHCWBdiscussed_in_filing Cybersecurity
topic_mentionHCWBdiscussed_in_filing Healthcare & Bio
topic_mentionHCWBdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001193125-26-134934EDGAR109K words
2025-03-282024-12-310000950170-25-046724EDGAR—
2024-04-012023-12-310000950170-24-039384EDGAR—
2023-03-282022-12-310000950170-23-010315EDGAR—
2022-03-292021-12-310000950170-22-004847EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001193125-25-283238EDGAR44K words
2025-08-182025-06-300000950170-25-109642EDGAR—
2025-05-152025-03-310000950170-25-072833EDGAR—
2024-11-142024-09-300000950170-24-127198EDGAR—
2024-08-142024-06-300000950170-24-097121EDGAR—
2024-05-152024-03-310000950170-24-060599EDGAR—
2023-11-142023-09-300000950170-23-063359EDGAR—
2023-08-112023-06-300000950170-23-041607EDGAR—
2023-05-092023-03-310000950170-23-019142EDGAR—
2022-11-072022-09-300000950170-22-022697EDGAR—
2022-08-122022-06-300000950170-22-017015EDGAR—
2022-05-132022-03-310000950170-22-009794EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-310001193125-26-134936EDGAR4K words
2026-03-170001193125-26-109407EDGAR—
2026-03-020001193125-26-084291EDGAR—
2026-02-190001193125-26-059578EDGAR—
2026-02-130001193125-26-049953EDGAR—
2025-12-310001193125-25-338026EDGAR—
2025-11-200001193125-25-289873EDGAR—
2025-11-190001193125-25-286642EDGAR—
2025-11-180001193125-25-285325EDGAR—
2025-11-140001193125-25-283230EDGAR—

119 total filings indexed. 92 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001828673
TickerHCWB
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 95b27f63204675a35d4cb9f4a026505173e7762033b0ac59572d42d9792ac177
parent: 5f007569e36bfa99a93f2c2d9fe0b37d534268013047c1fa5cec97780c0fd92f
content hash: 19b34d98903827e886ef5c8e5fdaf66ac5c4957b71bd1275bc35d446f7138f71
signed: 2026-04-13T04:45:27.947Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf